|
Market Closed -
Nasdaq
16:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 1.380 USD | +2.22% |
|
+20.00% | +24.32% |
Company Valuation: Celularity Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | - | 632.1 | 187.1 | 47.24 | 46.77 | 31.61 |
| Change | - | - | -70.41% | -74.75% | -1% | -32.41% |
| Enterprise Value (EV) 1 | - | 626 | 238.7 | 112.4 | 114.9 | 100.1 |
| Change | - | - | -61.87% | -52.9% | 2.17% | -12.81% |
| P/E | -1.27x | -3.43x | 14.3x | -0.22x | -0.79x | -0.31x |
| PBR | -4.97x | 6.4x | 0.97x | 1.17x | 5.31x | -0.84x |
| PEG | - | 0x | -0x | 0x | 0x | -0x |
| Capitalization / Revenue | - | 29.6x | 10.4x | 2.07x | 0.86x | 1.19x |
| EV / Revenue | - | 29.3x | 13.3x | 4.94x | 2.12x | 3.77x |
| EV / EBITDA | - | -4.86x | -1.72x | -1.67x | -3.75x | -1.85x |
| EV / EBIT | - | -4.55x | -1.61x | -1.47x | -2.98x | -1.69x |
| EV / FCF | - | -12.5x | -3.46x | -4.74x | 11.1x | 18.6x |
| FCF Yield | - | -7.97% | -28.9% | -21.1% | 8.99% | 5.38% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -86.9 | -14.93 | 0.9 | -11.02 | -2.645 | -3.586 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 14.28 | 21.34 | 17.98 | 22.77 | 54.22 | 26.55 |
| EBITDA 1 | -69.92 | -128.9 | -138.8 | -67.16 | -30.63 | -54.01 |
| EBIT 1 | -78.09 | -137.7 | -148.3 | -76.48 | -38.55 | -59.4 |
| Net income 1 | -208.2 | -100.1 | 14.19 | -196.3 | -57.89 | -91.72 |
| Net Debt 1 | -23.67 | -6.104 | 51.62 | 65.19 | 68.1 | 68.54 |
| Reference price 2 | 110.000 | 51.200 | 12.900 | 2.474 | 2.080 | 1.110 |
| Nbr of stocks (in thousands) | - | 12,346 | 14,501 | 19,095 | 22,484 | 28,479 |
| Announcement Date | 3/29/21 | 3/31/22 | 3/31/23 | 7/30/24 | 5/8/25 | 4/30/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 43.81M | |
| 32.9x | 11.93x | 24.23x | 0.6% | 1,031B | |
| 29.45x | 6.54x | 18.31x | 2.02% | 638B | |
| 33.1x | 7.75x | 16.02x | 2.65% | 462B | |
| 105.72x | 5.91x | 25.05x | 2.35% | 359B | |
| 19x | 4.63x | 11.48x | 2.87% | 335B | |
| 20.37x | 5.28x | 13.08x | 3.03% | 273B | |
| 20.79x | 4.31x | 12.28x | 2.05% | 253B | |
| 26.62x | 6.92x | 12.32x | 2.39% | 228B | |
| -45.08x | 6.57x | 25.65x | 2.21% | 185B | |
| Average | 26.98x | 6.65x | 17.60x | 2.24% | 376.39B | |
| Weighted average by Cap. | 32.10x | 7.72x | 18.90x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CELU Stock
- Valuation Celularity Inc.
Select your edition
All financial news and data tailored to specific country editions
